Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $643.4400 (-1.4%) ($643.4400 - $643.4400) on Mon. Nov. 22, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.82% (three month average) | RSI | 52 | Latest Price | $643.4400(-1.4%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.1% a day on average for past five trading days. | Weekly Trend | REGN advances 1.2% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Rotation from growth to value for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(52%) DIA(39%) XLV(39%) IWD(38%) SPY(37%) | Factors Impacting REGN price | REGN will decline at least -0.91% in a week (0% probabilities). VIXM(-20%) TBT(-8%) UUP(-7%) VXX(-5%) IGOV(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.91% (StdDev 1.82%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $647.17(-0.58%) | 10 Day Moving Average | $638.73(0.74%) | 20 Day Moving Average | $632.4(1.75%) | To recent high | -6% | To recent low | 18.5% | Market Cap | $68.223b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |